Revlimid® (lenalidomide) – ACCREDO SERVICES

Accredo Nova Factor is a member of the RevAssist SM program and qualified to dispense REVLIMID. Because of potential toxicity, REVLIMID is only available to select and trained prescribers and pharmacists who are registered and have completed the required training of the RevAssist SM program.

The Accredo Nova Factor intake team researches the patient's benefits and the reimbursement team bills the insurance company for the drug. The pharmacy team fills the prescription, answers clinical questions and counsels and monitors patients to ensure compliance with the treatment regimen. Our convenient service allows the healthcare provider to focus on patients and it allows the patient to get the therapy he or she needs without concerns about complicated insurance benefits.

If you have any questions about REVLIMID, contact the Accredo Nova Factor Revlimid Team.

Revlimid is a registered trademark of Celgene Corporation.